Tran Nguyen
Chief Financial Officer, METABASIS THERAPEUTICS INC.
Companies
- PROTHENA CORP PUBLIC LTD COChief financial officer Apr 2, 2013 to now1
- Rain Oncology Inc.Board member Apr 22, 2021 to Jan 26, 20242
- PROTHENA CORP PUBLIC LTD COOfficer Mar 1, 2019 to Feb 26, 20213
- Sierra Oncology, Inc.Board member Mar 24, 2016 to Jun 12, 20194
- PROTHENA CORP PUBLIC LTD COChief operating officer Jun 25, 2018 to Jun 25, 20185
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- PROTHENA CORP PUBLIC LTD CO PRTA40,205 shares6$340.1K at $8.46Jul 28, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 28, 2026Returned to company 57,000 shares at $8.56 of PROTHENA CORP PUBLIC LTD CO6
- Jul 28, 2026Exercised options 57,000 shares of PROTHENA CORP PUBLIC LTD CO6
- Jul 28, 2025Granted 95,000 shares of PROTHENA CORP PUBLIC LTD CO7
- May 17, 2023Sold 100 shares at $76.04 of PROTHENA CORP PUBLIC LTD CO8
- May 17, 2023Sold 9,215 shares at $75.44 of PROTHENA CORP PUBLIC LTD CO8
- May 17, 2023Sold 37,044 shares at $74.55 of PROTHENA CORP PUBLIC LTD CO8
- May 17, 2023Sold 34,640 shares at $73.54 of PROTHENA CORP PUBLIC LTD CO8
- May 17, 2023Sold 14,001 shares at $72.66 of PROTHENA CORP PUBLIC LTD CO8
- May 17, 2023Exercised options 50,000 shares at $22.85 of PROTHENA CORP PUBLIC LTD CO8
- May 17, 2023Exercised options 45,000 shares at $29.81 of PROTHENA CORP PUBLIC LTD CO8
- Mar 15, 2023Sold 5,198 shares at $48.68 of PROTHENA CORP PUBLIC LTD CO9
- Mar 15, 2023Sold 4,802 shares at $48.16 of PROTHENA CORP PUBLIC LTD CO9
- Mar 15, 2023Exercised options 10,000 shares at $6.73 of PROTHENA CORP PUBLIC LTD CO9
- Feb 15, 2023Sold 664 shares at $53.87 of PROTHENA CORP PUBLIC LTD CO10
- Feb 15, 2023Sold 9,336 shares at $53.30 of PROTHENA CORP PUBLIC LTD CO10
- Feb 15, 2023Exercised options 10,000 shares at $6.73 of PROTHENA CORP PUBLIC LTD CO10
- Jan 18, 2023Sold 638 shares at $56.97 of PROTHENA CORP PUBLIC LTD CO11
- Jan 18, 2023Sold 2,085 shares at $56.32 of PROTHENA CORP PUBLIC LTD CO11
- Jan 18, 2023Sold 7,277 shares at $55.18 of PROTHENA CORP PUBLIC LTD CO11
- Jan 18, 2023Exercised options 10,000 shares at $6.73 of PROTHENA CORP PUBLIC LTD CO11
- Dec 21, 2022Sold 6,845 shares at $59.21 of PROTHENA CORP PUBLIC LTD CO12
- Dec 21, 2022Sold 3,155 shares at $58.46 of PROTHENA CORP PUBLIC LTD CO12
- Dec 21, 2022Exercised options 10,000 shares at $6.73 of PROTHENA CORP PUBLIC LTD CO12
- Nov 23, 2022Sold 1,469 shares at $62.28 of PROTHENA CORP PUBLIC LTD CO13
- Nov 23, 2022Sold 3,984 shares at $61.28 of PROTHENA CORP PUBLIC LTD CO13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARRain Oncology Inc., Board member
- 3SEC EDGARPROTHENA CORP PUBLIC LTD CO, Officer
- 4SEC EDGARSierra Oncology, Inc., Board member
- 5
- 6
- 7SEC EDGARForm 4 filed Jul 30, 2025
- 8SEC EDGARForm 4 filed May 17, 2023
- 9SEC EDGARForm 4 filed Mar 17, 2023
- 10SEC EDGARForm 4 filed Feb 17, 2023
- 11SEC EDGARForm 4 filed Jan 20, 2023
- 12SEC EDGARForm 4 filed Dec 23, 2022
- 13SEC EDGARForm 4 filed Nov 25, 2022